HIV Therapeutics

See allHide authors and affiliations

Science  28 Jun 1996:
Vol. 272, Issue 5270, pp. 1886
DOI: 10.1126/science.272.5270.1886


Douglas Richman (University of California at San Diego, USA) captures the current excitement in the field of HIV therapeutics. New drugs, new treatment regimens, and new insights into the relation of disease progression to the quantity of viral RNA in patients' plasma have led to an unprecedented sense of optimism among researchers.